期刊文献+

原发性肝癌组织中RANTES的表达与微血管密度的关系 被引量:3

Relationship between expression of RANTES and microvascular density in tissues of primary hepatocarcinoma
下载PDF
导出
摘要 目的研究原发性肝癌(PHC)组织中受激活调节正常T细胞表达和分泌因子(RANTES)的表达和微血管密度(MVD)的关系,并探讨其临床意义。方法选择47例PHC癌组织和癌旁组织标本,免疫组织化学法检测组织中RANTES的表达并计算MVD,分析RANTES表达、MVD与PHC临床病理特征的关系,并探讨两者的相关性。结果癌组织中RANTES的阳性表达率和表达评分均显著高于癌旁组织(55.32%vs 19.15%、1.89±1.77 vs 0.77±1.29)(均P<0.01);癌组织中MVD显著高于癌旁组织(67.30±13.68 vs 37.20±10.58)(P<0.01);除伴转移病例癌组织中MVD高于无转移病例[(73.50±13.77)/HP vs(64.10±12.68)/HP](P<0.05)外,RANTES表达、MVD与PHC的其他病理特征无明显关系。相关性分析显示,癌组织中RANTES表达评分与MVD呈正相关(r=0.386,P<0.05)。结论RANTES可能与PHC的血管生成有密切关系。 Objective To investigate the relationship between the expression of regulated-upon activation normal T expressed and secreted (RANTES) and microvascular density (MVD) in hepatocarcinoma (PHC) tissues, and explore its clinical significance. Methods The samples of PHC tissues and adjacent tissues in 47 patients were collected. The expression of RANTES in tissues was detected by immunohistochemistry, and MVD was calculated. The relationship among the expression of RANTES, MVD and clinicopathological features was analysed. Results The positive expression rate and expression score of RANTES in PHC tissues were significantly higher than those in adjacent tissues (55.32% vs 19.15%, P 〈0.01; 1.89 ± 1.77 vs 0. 77 ± 1.29, P 〈 0.01). MVD in PHC tissues was significantly higher than that in adjacent tissues (67.30 ± 13.68 vs 37.20 ± 10.58, P 〈 0.01). MVD of PHC tissues in patients with metastasis was significantly higher than that in patients without metastasis [(73.50 ± 13.77)/HP vs (64.10 ± 12.68)/HP, P 〈0.05], while there were no correlations among MVD, expression of RANTES and the other clinieopathological features of PHC. MVD was positively correlated with the expression score of RANTES in PHC tissues ( r = 0. 386, P 〈 0.05). Conclusion RANTES might be closely related to the angiogenesis in PHC.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第2期222-224,243,共4页 Journal of Shanghai Jiao tong University:Medical Science
关键词 原发性肝癌 微血管密度 趋化因子 免疫组织化学法 primary hepatocarcinoma microvascular density chemokines immunohistochemistry
  • 相关文献

参考文献9

  • 1Popiela TJ, Sikora J, Klimek M, et al. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases[ J]. Neuro Endoetinol Lett, 2008, 29(4) : 443 -446.
  • 2Soria G, Yaal-Hahoshen N, Azenshtein E, et al. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions [J]. Cytokine, 2008, 44(1) : 191 -200.
  • 3元云飞,李锦清,李斌奎,张亚奇,李国辉.影响肝细胞肝癌切除术后长期生存的相关因素[J].中国实用外科杂志,2004,24(10):608-611. 被引量:9
  • 4Foote RL, Weidner N, Harris J, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505 [J]. Int J Radiat Oncol Biol Phys, 2005, 61 (3): 745 -753.
  • 5向志钢,杨竹林,邓星辉.肝细胞癌中Arom和elastin的表达及其临床意义[J].中国普通外科杂志,2008,17(8):816-819. 被引量:1
  • 6Sofia G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer[ J]. Cancer Lett, 2008, 267 (2) : 271 - 285.
  • 7Adler EP, l,emken CA, Katchen NS, et al. A dual role for tumorderived chemokine RANTES (CCL5)[J]. Immunol Lett, 2003, 90 (2-3): 187-194.
  • 8Azenshtein E, Luboshits G, Shina S, et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity[J]. Cancer Res, 2002, 62(4) : 1093 - 1102.
  • 9Bernardini G, Ribatti D, Spinetti G, et al. Analysis of the role of chemokines in angiogenesis [ J ]. J Immunol Methods, 2003, 273 (1-2): 83-101.

二级参考文献21

  • 1周信达,汤钊猷,余业勤,杨秉辉,马曾辰,陆继珍,林芷英,叶胜龙,吴志全.肝癌多模式治疗的远期疗效[J].中华外科杂志,1996,34(9):518-521. 被引量:34
  • 2Atsushi Sugioka,Toshiharu Tsuzuki,Toshio Kanai.Postresection prognosis of patients with hepatocellular carcinoma.Surgery,1993,113(6):612-618
  • 3Vauthey JN,Klimstra D,Franceschi D,et al.Factors affecting long term outcome after hepatic resection for hepatocellular carcinoma.Am J Surg,1995,169:28-356 Bilimoria MM,Lauwers GY,Doherty DA,et al.Underlying liver disease,not tumor factors,predicts long-t
  • 4Tsai TJ,Chau GY,Lui WY,et al.Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.Surgery,2000,127(6):603-608
  • 5Vauthey JN,Lauwers GY,Esnaola NF,et al.Simplified staging for hepatocellular carcinoma.J Clin Oncol,2002,20(6):1527-1536
  • 6Liver including intrahepatic bile ducts.In:Greece FL,Page DL,Fleming ID,et al,editors.American Joint Committee on Cancer staging manual.6th edition.New York:Springer; 2002.131-144
  • 7Meinhardt U, Mullis PE. The aromatase cytochrome p-450 and its clinical impact [ J ]. Horm Res, 2002,57 (5 - 6) :145 - 152.
  • 8Lapis K, Timar J. Role of elastin-matrix interactions in tumor progression [ J ]. Semin Cancer Biol, 2002, 12 (3) :209 -217.
  • 9Yamaguchi Y, Takei H, Suemasu K, et al. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer [J]. Cancer Res,2005,65(11) :4653 - 4662.
  • 10Isnard N, Peterszegi G, Robert AM, et al. Regulation of elastase-type endopeptidase activity, MMP-2 and MMP-9 expression and activation in human dermal fibroblasts by fucose and a fucose-rich polysaccharide [ J ] . Biomed Pharmacother,2002, 56(5) :258 -264.

共引文献8

同被引文献36

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部